Skip navigation


Current DateTime: 09:52:55 23 Nov 2009
LinksList Documentid: 24355697
  • Runway Angels

      The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.

  • Smartphone Guide

      Here's a need-to-know guide to nine devices, based on features, price, network and platform.

  • Wines for the Holidays

      Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES


Current DateTime: 09:52:55 23 Nov 2009
LinksList Documentid: 33793611
  • A Healthier & Wealthier You

      Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.

  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?

  • The Many Myths of Coca-Cola

      Can you tell which statements are true, and which ones are just rumors?


Current DateTime: 09:52:55 23 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
Seasonal flu may hit Europe after H1N1 - experts
By: AFX | 06 Nov 2009 | 09:13 AM ET
Text Size

By Kate Kelland STOCKHOLM, Nov 6 (Reuters) - The H1N1 pandemic flu virus could kill up to 40,000 people across Europe and be followed by seasonal flu waves that could kill the same number, European health experts said on Friday. The Sweden-based European Centre for Disease Prevention and Control said epidemics of H1N1, known as swine flu, were now affecting almost all countries in the European Union but it could not predict how intense the peaks would be. What was certain, it said, was that the pandemic would continue to kill thousands and put many patients into intensive care as the northern hemisphere's winter sets in. "All European countries will be affected, and this will put considerable stress on healthcare systems," said ECDC director Zsuzsanna Jakab. The ECDC, which monitors disease in the European Union and European free trade area (EFTA), said it was hard to predict what the mix of pandemic and seasonal flu viruses would bring but there was a risk of seasonal flu epidemics "early in 2010 when the pandemic waves have passed". Angus Nicoll, the ECDC's flu coordinator, said in non-pandemic situations, seasonal flu could kill up to 40,000 people in Europe -- and H1N1 could do the same. "That is not a trivial number," he said. "And the fact that H1N1 is happening in younger adults, pregnant women and people without risk factors ...

makes it feel different." RISKS AND DEATHS The ECDC said experience from the United States and the southern hemisphere showed pregnant women with the virus are 10 times more likely to need intensive care than those with no risk factors. Those with asthma and chronic respiratory diseases have three times the risk and the very obese six times the risk. But it also said evidence so far shows some 20 to 30 percent of H1N1 deaths are among healthy young people. The ECDC's latest daily update said all 27 EU and four EFTA countries have cases of H1N1 pandemic flu and there have been 389 deaths linked to H1N1 in the region since April, including 154 in Britain, 73 in Spain, 25 in Italy and 22 in France. The ECDC's global toll showed 6,005 fatal cases of H1N1 have been reported. The WHO, which updates its figures weekly, said on Thursday 5,712 people have died worldwide since H1N1 was discovered earlier this year. The ECDC said the numbers of fatal cases associated with pandemic flu were "likely to be gross underestimates" as access to healthcare and lab tests varied from country to country. GlaxoSmithKline and Sanofi-Aventis are among some 25 companies making pandemic vaccines, while other drugmakers including Roche are making antiviral therapies for use as frontline H1N1 treatment. Nicoll said vaccination programmes which started in some European countries in recent weeks were vital to protecting those most at risk but had come too late to halt the disease. "We're not trying at this stage to protect the whole of society with the vaccines. The strategy is to protect the vulnerable." (Editing by Janet Lawrence) Keywords: FLU/EUROPE (kate.kelland@thomsonreuters.com; +44 (0)7990 567 059) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • The show attracts a big TV audience every year, but this year it may take on even more importance.
  • …you'll want to be prepared. Tips for getting the most out of the post-Thanksgiving shopping frenzy.
  • Congressman Ron Paul explains to Squawk Box why he’s pushing legislation to audit the Federal Reserve.
  • CNBC’s Phil LeBeau took a test drive of GM’s flagship electric car. Here’s what he thought of the Volt.
  • The energy company Power Efficiency is building tools that regulate the power electric motors use.
  • CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.
ADD COMMENTS
Remaining characters


Current DateTime: 05:29:33 23 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 10:08:23 23 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 08:24:12 23 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:08:15 23 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters